Chondrogard vials 0.1/ml 1 ml n10

Dosage form

Solution for intramuscular injection

Composition

Chondrontine sulfate

Packaging

10 pieces

Mechanism of action

HONDROGARD improves phosphorus-calcium metabolism in cartilage, accelerates its recovery processes, stimulates the synthesis of glycosaminoglycans. The therapeutic effect can be observed as early as 2-3 weeks after the start of the drug administration: the pain decreases, the clinical manifestations of reactive synovitis disappear and the range of movements in the affected joints increases. Hondrogard® also reduces the degenerative changes in the cartilage and accelerates its recovery processes. It is important to note that the effect persists for a long time after the end of the course of treatment.

Indications and usage

Degenerative-dystrophic diseases of the joints and spine:

• osteoarthritis of peripheral joints
• intervertebral osteochondrosis and osteoarthrosis

Dosage and administration

The drug is administered intramuscularly in a dose of 100 mg every other day. With good endurance, the dose is increased to 200 mg, starting with the fourth injection. The course of treatment is 25-30 injections. If necessary, after 6 months, it is possible to repeat the course of treatment.